# TERIFLUNOMIDE
> **ANDA209677** · Abbreviated New Drug Application (Generic) · Sponsor: SOLA PHARMS · Approved 2020-06-17
## Drug
- **FDA Application Number:** ANDA209677
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TERIFLUNOMIDE
- **Generic name:** Teriflunomide
- **Active ingredients:** TERIFLUNOMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOLA PHARMS
- **First approval:** 2020-06-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209677)
---
*AI Analytics · CC0 1.0*